TRIM21 and autoimmune disease: As expected, the majority of patients (21 out of 28) belonging to the “definitive diagnosis” group has a systemic autoimmune disease as the relevant diagnosis (SLE+SS+PBC: 75%), although a minority Ro52 autoantibodies can also be detected in some other clinical conditions (organ-specific autoimmune diseases included).